MESA, AZ--(Marketwired - November 13, 2013) - Ulthera
, Inc. -- a global, high-growth medical device and specialty dermatology company with multiple aesthetic and medical applications -- today announced it will be participating in the 2013 Canaccord Genuity Medical Technology & Diagnostics Forum on Thursday, November 14 at The Westin New York Grand Central in New York, NY.
Ulthera's presentation is scheduled for Thursday, November 14, 2013 at 2:00 pm EST.
Ulthera, Inc. is a global, high-growth medical device and specialty dermatology company with multiple aesthetic and medical applications using its therapeutic ultrasound platform technology. The Ulthera® System is the first and only energy-based device to receive U.S. FDA clearance for a non-invasive aesthetic lift indication. It is used in a face and neck procedure known as Ultherapy®, which is cleared to lift skin above the brow, on the neck and under the chin. Founded in 2004 and based in Mesa, Ariz., Ulthera is a privately held company backed by top-tier venture capital firms, New Enterprise Associates and Apposite Capital. For more information, visit www.ultherapy.com.